Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premal Patel

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
International Journal of Impotence Research|July 14, 2021
Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100 mg IM weekly or 200 mg IM biweeklyFarouk M El-Khatib, Linda M Huynh, Alexei Kopelevich, et al.
Urology|September 20, 2020
Global Survey of the Roles and Attitudes Toward Social Media Platforms Amongst Urology TraineesJustin M Dubin, Aubrey B Greer, Premal Patel, et al.
Placenta|August 27, 2023
Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case seriesNada Mufti, Joanna Chappell, Patrick O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Evaluation and clinical analyses of downstream targets of the Akt inhibitor GDC-0068Yibing Yan, Violeta Serra, Ludmila Prudkin, et al.
BJU International|March 10, 2020
Global survey evaluating drawbacks of social media usage for practising urologistsJustin M Dubin, Aubrey B Greer, Premal Patel, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pre-Implementation Assessment of a Sexual Health eClinic in Canadian Oncology CareTaylor Incze, Dalia Peres, Steven Guirguis, et al.
Cancer Discovery|November 23, 2016
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid TumorsCristina Saura, Desamparados Roda, Susana Roselló, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
International Journal of Impotence Research|July 14, 2021
Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100 mg IM weekly or 200 mg IM biweeklyFarouk M El-Khatib, Linda M Huynh, Alexei Kopelevich, et al.
Urology|September 20, 2020
Global Survey of the Roles and Attitudes Toward Social Media Platforms Amongst Urology TraineesJustin M Dubin, Aubrey B Greer, Premal Patel, et al.
Placenta|August 27, 2023
Use of super resolution reconstruction MRI for surgical planning in Placenta accreta spectrum disorder: Case seriesNada Mufti, Joanna Chappell, Patrick O'Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
Evaluation and clinical analyses of downstream targets of the Akt inhibitor GDC-0068Yibing Yan, Violeta Serra, Ludmila Prudkin, et al.
BJU International|March 10, 2020
Global survey evaluating drawbacks of social media usage for practising urologistsJustin M Dubin, Aubrey B Greer, Premal Patel, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Pre-Implementation Assessment of a Sexual Health eClinic in Canadian Oncology CareTaylor Incze, Dalia Peres, Steven Guirguis, et al.
Cancer Discovery|November 23, 2016
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid TumorsCristina Saura, Desamparados Roda, Susana Roselló, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2014
Biomarker analyses from a placebo-controlled phase II study evaluating erlotinib±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefitHartmut Koeppen, Wei Yu, Jiping Zha, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast CancerChristian D Young, Lisa J Zimmerman, Daisuke Hoshino, et al.
Pageof 17